Purpose— The aim of this guideline is to present current and comprehensive recommendations
for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage (aSAH). …

Western societies with an estimated incidence of 10 to 25 per 100 000 persons. 1–3
Despite advances in the field of stroke and neurocritical care, 4 the 30-day mortality has not …

This invited special report is based on an award presentation at the World Stroke
Organization/European Stroke Organization Conference in November of 2020 outlining progress in …

… Naidech received support for article research from the Agency for Healthcare Research and
Quality (K18 HS023437). Dr. Pun received funding from the Society of Critical Care Medicine…

Background Aneurysm rebleeding has historically been an important cause of mortality after
subarachnoid hemorrhage (SAH). Objective To describe the frequency and impact of …

Background— Cardiac troponin I (cTI) release occurs frequently after subarachnoid
hemorrhage (SAH) and has been associated with a neurogenic form of myocardial injury. The …

Background and Purpose— Phenytoin (PHT) is routinely used for seizure prophylaxis after
subarachnoid hemorrhage (SAH), but may adversely affect neurologic and cognitive recovery…

Damage to specific brain circuits can cause specific neuropsychiatric symptoms. Therapeutic
stimulation to these same circuits may modulate these symptoms. To determine whether …

Objective: To compare the efficacy of a novel water-circulating surface cooling system with
conventional measures for treating fever in neuro-intensive care unit patients. Design: …

Background and Purpose— There are few data on the effectiveness and side effects of
antiepileptic drug therapy after intracerebral hemorrhage. We tested the hypothesis that …